| Model Number |
C315S502 |
| Medical Device Problem Codes |
Accessory Incompatible (1004); Break (1069); Material Integrity Problem (2978)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/28/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the implantable pacing lead (ipl) was placed as needed and during the delivery catheter slitting process, the cut was not smooth and damage occurred midway.The ipl was noted to have dislodged during the delivery catheter slitting.A new delivery catheter, and slitter was used to implant a new lead.No patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Product event summary: the delivery catheter was returned and analyzed.The shaft on the hub of the delivery catheter was spiral slit.The shaft of the delivery catheter was spiral slit.The peeling/slitting/splitting was not slit on the center of hub of the delivery catheter.Visual analysis of the delivery catheter indicated damage during use.The analyst noted the delivery catheter was returned without the dilator.Slitting did not start on the centerline on the hub of the delivery catheter.The hub of the delivery catheter was spiral slit.The shaft of the delivery catheter was spiral slit.Slitting had terminated at 9.9 cm.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|